These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35234907)

  • 41. Prevalence of Multidrug-Resistant Organisms in Hospitalized Pediatric Refugees in an University Children's Hospital in Germany 2015-2016.
    Tenenbaum T; Becker KP; Lange B; Martin A; Schäfer P; Weichert S; Schroten H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1310-1314. PubMed ID: 27523304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study.
    Giufrè M; Ricchizzi E; Accogli M; Barbanti F; Monaco M; Pimentel de Araujo F; Farina C; Fazii P; Mattei R; Sarti M; Barozzi A; Buttazzi R; Cosentino M; Nardone M; Savini V; Spigaglia P; Pantosti A; Moro ML; Cerquetti M
    Clin Microbiol Infect; 2017 Dec; 23(12):961-967. PubMed ID: 28412380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 - survey results from the RH(E)IN-CARE network.
    Tschudin-Sutter S; Lavigne T; Grundmann H; Rauch J; Eichel VM; Deboscker S; Jaulhac B; Mutters NT
    Swiss Med Wkly; 2021 Mar; 151():w20454. PubMed ID: 33705560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome.
    Nemeth J; Ledergerber B; Preiswerk B; Nobile A; Karrer S; Ruef C; Kuster SP
    J Hosp Infect; 2012 Dec; 82(4):254-9. PubMed ID: 23103249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-country cross-sectional study of colonization with multidrug-resistant organisms: protocol and methods for the Antibiotic Resistance in Communities and Hospitals (ARCH) studies.
    Sharma A; Luvsansharav UO; Paul P; Lutgring JD; Call DR; Omulo S; Laserson K; Araos R; Munita JM; Verani J; Chowdhury F; Muneer SM; Espinosa-Bode A; Ramay B; Cordon-Rosales C; Kumar CPG; Bhatnagar T; Gupta N; Park B; Smith RM
    BMC Public Health; 2021 Jul; 21(1):1412. PubMed ID: 34271883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
    Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
    BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS).
    Maechler F; Peña Diaz LA; Schröder C; Geffers C; Behnke M; Gastmeier P
    Infection; 2015 Apr; 43(2):163-8. PubMed ID: 25395161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial Resistance in Organ Transplant Recipients.
    Giannella M; Rinaldi M; Viale P
    Infect Dis Clin North Am; 2023 Sep; 37(3):515-537. PubMed ID: 37244806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaginal colonization with antimicrobial-resistant bacteria among women in labor in central Uganda: prevalence and associated factors.
    Tumuhamye J; Steinsland H; Bwanga F; Tumwine JK; Ndeezi G; Mukunya D; Namugga O; Kasede AN; Sommerfelt H; Nankabirwa V
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):37. PubMed ID: 33597029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.
    Wang J; Foxman B; Mody L; Snitkin ES
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10467-10472. PubMed ID: 28900004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low prevalence of zoonotic multidrug-resistant bacteria in veterinarians in a country with prudent use of antimicrobials in animals.
    Verkola M; Pietola E; Järvinen A; Lindqvist K; Kinnunen PM; Heikinheimo A
    Zoonoses Public Health; 2019 Sep; 66(6):667-678. PubMed ID: 31232511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012].
    Heudorf U; Gustav C; Mischler D; Schulze J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Apr; 57(4):414-22. PubMed ID: 24658671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
    Çaǧlayan Ç; Barnes SL; Pineles LL; Harris AD; Klein EY
    Front Public Health; 2022; 10():853757. PubMed ID: 35372195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals.
    Heudorf U; Albert-Braun S; Hunfeld KP; Birne FU; Schulze J; Strobel K; Petscheleit K; Kempf VA; Brandt C
    GMS Hyg Infect Control; 2016; 11():Doc16. PubMed ID: 27579250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
    Mascitti H; Duran C; Nemo EM; Bouchand F; Câlin R; Descatha A; Gaillard JL; Lawrence C; Davido B; Barbier F; Dinh A
    Antimicrob Resist Infect Control; 2018; 7():116. PubMed ID: 30288256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.
    Ma X; Wu Y; Li L; Xu Q; Hu B; Ni Y; Wu A; Sun S; Jarlier V; Robert J
    BMC Infect Dis; 2015 Aug; 15():358. PubMed ID: 26290050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study.
    Gerlich MG; Piegsa J; Schäfer C; Hübner NO; Wilke F; Reuter S; Engel G; Ewert R; Claus F; Hübner C; Ried W; Flessa S; Kramer A; Hoffmann W
    BMC Infect Dis; 2015 Oct; 15():441. PubMed ID: 26493394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
    Leung W; Malhi G; Willey BM; McGeer AJ; Borgundvaag B; Thanabalan R; Gnanasuntharam P; Le B; Weizman AV; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    J Crohns Colitis; 2012 Aug; 6(7):743-9. PubMed ID: 22398097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.